Lofexidine
RxNorm 28863
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 28863 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: lofexidine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Lofexidine
(Atom ID: 433705)
PTPrescribable
Designated preferred name (PT):
Lofexidine
(Atom ID: 433709)
FNPrescribable
Full form of descriptor (FN):
Lofexidine (substance)
(Atom ID: 433714)
PTPrescribable
Designated preferred name (PT):
Lofexidine-containing product
(Atom ID: 10806196)
FNPrescribable
Full form of descriptor (FN):
Product containing lofexidine (medicinal product)
(Atom ID: 9259105)
Patient Education
Lofexidine
Lofexidine is used to manage opioid withdrawal symptoms (e.g., sick feeling, stomach cramps, muscle spasms or twitching, cold sensation, heart pounding, muscle tension, aches and pains, yawning, runny eyes, or difficulty falling asleep or staying asleep) that may occur after an opioid medication is suddenly stopped. Lofexidine is in a class of medications called central alpha adrenergic agonists. It works by relaxing blood vessels so that blood can flow more easily through the body.
[Learn More]
* Please review the disclaimer below.